- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00808340
Comparison of Three Soft Bifocal Contact Lenses
June 18, 2018 updated by: Johnson & Johnson Vision Care, Inc.
The primary purpose of the study is to compare the performance of three soft bifocal contact lenses in terms of the vision provided by the lenses.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
37
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Virginia
-
Roanoke, Virginia, United States, 24153
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
35 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The subject must between 35 and 70 years of age.
- The subject must respond positively to at least one symptom on the "Presbyopic Symptoms Questionnaire" or be already wearing presbyopic contact lens correction ( e.g. reading spectacles over contact lenses, multifocal or monovision contact lenses etc.).
- The subject's spherical equivalent distance refraction must be in the range of -1.00 to -6.00 in each eye.
- Refractive cylinder must be less than or equal to -0.75 D in each eye.
- The subject must have an add power of +0.75D to +2.50D in each eye.
- The subject must have best corrected visual acuity of 20/20-3 or better in each eye.
- The subject's must have at least 20/30-distance vision with the study contact lenses.
- The subject must agree that they are comfortable with their vision prior to being dispensed the study lenses.
- The subject must be an adapted soft contact lens wearer in both eyes.
- The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
- The subject must read and sign the STATEMENT OF INFORMED CONSENT and be provided a copy of the form.
Exclusion Criteria:
- Ocular or systemic allergies or disease that may interfere with contact lens wear.
- Systemic disease, autoimmune disease or use of medication, which may interfere with contact lens wear.
- Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal staining or any other abnormality of the cornea, which may contraindicate contact lens wear.
- Clinically significant (grade 3 or 4) tarsal abnormalities that might interfere with contact lens wear.
- Any ocular infection.
- Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
- Pregnancy or lactation
- Any infectious disease (e.g., hepatitis, tuberculosis) or a contagious immunosuppressive disease (e.g., HIV).
- History of diabetes. History of binocular vision abnormality or strabismus.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: senofilA test/senofilA prod/balafilconA
Subjects wear 3 multifocal contact lenses: senofilcon A test worn first, senofilcon A production worn second, and balafilcon A worn third.
|
multifocal contact lens
multifocal contact lens
multifocal contact lens
|
|
Active Comparator: senofilcon A test/balafilcon A/senofilcon A prod
Subjects wear 3 multifocal contact lenses: senofilcon A test worn first, balafilcon A worn second, and senofilcon A production worn third.
|
multifocal contact lens
multifocal contact lens
multifocal contact lens
|
|
Active Comparator: senofilcon A prod/senofilcon A test/balafilcon A
Subjects wear 3 multifocal contact lenses: senofilcon A production worn first, senofilcon A test worn second, and balafilcon A worn third.
|
multifocal contact lens
multifocal contact lens
multifocal contact lens
|
|
Active Comparator: senofilcon A prod/ balifilcon A/ senofilcon A test
Subjects wear 3 multifocal contact lenses: senofilcon A production worn first, balafilcon A worn second, and senofilcon A test worn third.
|
multifocal contact lens
multifocal contact lens
multifocal contact lens
|
|
Active Comparator: balafilcon A/senofilcon A test/senofilcon A prod
Subjects wear 3 multifocal contact lenses: balafilcon A worn first, senofilcon A test worn second, and senofilcon A production worn third.
|
multifocal contact lens
multifocal contact lens
multifocal contact lens
|
|
Active Comparator: balafilcon A/senofilcon A prod/senofilcon A test
Subjects wear 3 multifocal contact lenses: balafilcon A worn first, senofilcon A production worn second, senofilcon A test worn third.
|
multifocal contact lens
multifocal contact lens
multifocal contact lens
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Distance Bright Illumination Binocular Visual Performance Reported as Visual Acuity
Time Frame: 5 minutes after insertion
|
Tested with both eyes together in bright lighting, reading charts distant to the subject.
This outcome is measured in logMAR units.LogMAR stands for the logarithm of the minimum angle of resolution.
Ideal is 0.0 and represents 20/20 Snellen acuity.
logMAR values > 0.00 indicate vision poorer than the ideal and values <0.00 indicate vision greater than the ideal.
|
5 minutes after insertion
|
|
Near Bright Illumination Binocular Visual Performance Reported as Visual Acuity
Time Frame: 5 minutes after insertion
|
Tested with both eyes together in bright lighting reading charts near to the subject.
This outcome is measured in logMAR units.LogMAR stands for the logarithm of the minimum angle of resolution.
Ideal is 0.0 and represents 20/20 Snellen acuity.
logMAR values > 0.00 indicate vision poorer than the ideal and values <0.00 indicate vision greater than the ideal.
|
5 minutes after insertion
|
|
Type of Corneal Staining
Time Frame: after 1 week of lens wear, for each lens type
|
Investigator rated type of corneal staining as either 0=none, 1=micropunctate, 2=macropunctate, 3=coalesced, or 4=patch(> or = to mm).
|
after 1 week of lens wear, for each lens type
|
|
Overall Subjective Vision
Time Frame: after 1 week of lens wear, for each lens type
|
Subject rated the overall quality of vision with the study contact lenses.
5=excellent, 4=very good, 3=good, 2=fair, 1=poor.
|
after 1 week of lens wear, for each lens type
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2008
Primary Completion (Actual)
December 1, 2008
Study Completion (Actual)
December 1, 2008
Study Registration Dates
First Submitted
December 12, 2008
First Submitted That Met QC Criteria
December 12, 2008
First Posted (Estimate)
December 15, 2008
Study Record Updates
Last Update Posted (Actual)
June 19, 2018
Last Update Submitted That Met QC Criteria
June 18, 2018
Last Verified
August 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CR-1485FA
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Presbyopia
-
Ohio State UniversityRecruitingPresbyopia | Presbyopia CorrectionUnited States
-
Bruno Vision Careiuvo BioScience Operations, LLCCompleted
-
Johnson & Johnson Vision Care, Inc.CompletedPresbyopia CorrectionUnited Kingdom
-
VIS, Inc.Active, not recruitingPresbyopia Correction
-
AST Products, Inc.CompletedCataract | Presbyopia CorrectionSpain
-
IROC AGAMO IrelandActive, not recruitingCataract | Presbyopia CorrectionSwitzerland
-
Bausch & Lomb IncorporatedCompletedMyopia and Hyperopia and PresbyopiaUnited States
-
Technolas Perfect Vision GmbHUnknownHyperopic PresbyopiaIreland
-
The Hong Kong Polytechnic UniversityNot yet recruitingPresbyopia | Presbyopia Correction
-
University Eye Hospital SvjetlostCompletedCataract | Visual Acuity | Presbyopia CorrectionCroatia
Clinical Trials on balafilcon A
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedCorneal Infiltrative Events | Corneal InflammationUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.University of ManchesterCompleted
-
University of WaterlooAlcon ResearchCompleted
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedAstigmatismAustralia, United States
-
Johnson & Johnson Vision Care, Inc.Completed